市場調查報告書

全球細胞治療市場預測

Global Cell Therapy Market Research Report Forecast to 2023

出版商 Market Research Future 商品編碼 879104
出版日期 內容資訊 英文 96 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球細胞治療市場預測 Global Cell Therapy Market Research Report Forecast to 2023
出版日期: 2019年05月31日內容資訊: 英文 96 Pages
簡介

本報告提供全球細胞治療市場相關調查分析,提供市場概要,市場趨勢,推動市場的要素/抑制因素等相關考察,各類型,各產品,各治療法,各終端用戶,各地區市場分析,主要企業的簡介等相關整體分析。

第1章 摘要整理

第2章 市場簡介

第3章 調查方法

第4章 市場動態

  • 簡介
  • 促進要素
  • 抑制因素
  • 機會

第5章 市場因素分析

  • 臨床實驗資料
  • 法規的指南

第6章 全球細胞治療市場:各類型

  • 概要
  • 自我細胞
  • 同類細胞

第7章 全球細胞治療市場:各產品

  • 概要
  • 消耗品(血管/媒體/血清/試劑)
  • 設備
  • 軟體/其他服務

第8章 全球細胞治療市場:各治療法

  • 概要
  • 幹細胞治療
  • 細胞疫苗
  • 繼子細胞移植(ACT)
  • 纖維母細胞治療
  • 軟骨細胞治療

第9章 全球細胞治療市場:各技術

  • 概要
  • 病毒·媒介
  • 細胞不死化
  • 基因編輯

第10章 全球細胞治療市場:各細胞源

  • 概要
  • 骨髓
  • 脂肪組織
  • 臍帶血原來細胞

第11章 全球細胞治療市場:各用途

  • 概要
  • 癌症
  • 心臟血管疾病(CDV)
  • 整形外科
  • 創傷治療

第12章 全球細胞治療市場:各終端用戶

  • 概要
  • 醫院/診所
  • 再生醫療中心
  • 研究機關

第13章 全球細胞治療市場:各地區

  • 簡介
  • 南北美洲
  • 歐洲
  • 亞太地區
  • 中東/非洲

第14章 競爭情形

第15章 企業簡介

  • Mesoblast Ltd
  • Vericel Corporation
  • Osiris Therapeutics, Inc.
  • JCR Pharmaceuticals Co., Ltd
  • NuVasive, Inc.
  • Pharmicell Co., Ltd
  • RTI Surgical Holdings, Inc.
  • AlloSource
  • Holostem Terapie Avanzate S.r.l.
  • Medipost Co., Ltd

第16章 附錄

目錄

Cell Therapy Market Report: Information by Type (Autologous & Allogeneic), Product (Consumables (Vessel/Media/Serum/Reagent), Equipment, & Software & Other Services), Technique End User (Hospitals & Clinics & Others), & Region-Forecast till 2023

Market analysis

Cell treatment includes the organization of physical cell arrangements for the treatment of sicknesses or any other traumatic damages. The target of this examination is to give long haul treatment through a solitary infusion of restorative cells. The increasing number of growing populace, the ascent in cell treatment transplantations all around, and rising ailment awareness are driving the development of the global cell therapy market. In any case, stringent administrative arrangements may hamper the development of the market. The global cell therapy market is projected to register a CAGR of 22.36% to reach USD 20,217.00 million by 2023.

Market segmentation

The Global Cell Therapy Market is segmented based on its type, product, technique, technology, cell source, application, end-user, and regional demand. Based on its type, the market is segmented as Allogeneic and Autologous. On the basis of its product, the market is bifurcated into Equipment, Consumables (Vessel/Media/Serum/Reagent), Software & Other Services. Based on its technique, the market is divided into Adoptive Cell Transfer (ACT), Cell Vaccine, Fibroblast Cell Therapy, Stem Cell Therapy, Chondrocyte Cell Therapy. On the basis of its technology, the market is segmented into Cell Immortalization Technology, Viral Vector Technology, Genome Editing Technology. Based on its Cell Source, the market is bifurcated into Adipose Tissue, Bone Marrow, Umbilical Cord Blood-Derived Cells. On the basis of its Application, the market is segmented into Orthopedic, Cardiovascular Disease (CVD), Oncology, Wound Healing. Based on its End User, the market is segmented into Regenerative Medicine Centers, Hospital & Clinics, Research Institutes.

Regional demand

Geographically, the Global Cell Therapy Market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Pharmicell Co., Ltd, AlloSource, Holostem Terapie Avanzate S.r.l., Medipost Co., Ltd, Mesoblast Ltd, Vericel Corporation, Osiris Therapeutics, Inc, JCR Pharmaceuticals Co., Ltd, NuVasive, Inc., among others are some of the major players in the Global Cell Therapy Market.

Table of Contents

1 Executive Summery

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of the Study
  • 2.3 Assumptions & Limitations
    • 2.3.1 Assumptions
    • 2.3.2 Limitations
  • 2.4 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Rise in Number of Cell Therapy Clinical Studies
    • 4.2.2 Rising Adoption of Regenerative Medicine
  • 4.3 Restraints
    • 4.3.1 Ethical Concerns Related to Stem Cell Research
    • 4.3.2 Stringent Regulatory Policies
  • 4.4 Opportunities
    • 4.4.1 Entering Developing Economies

5 Market Factor Analysis

  • 5.1 Clinical Trial Data
  • 5.2 Regulatory Guidelines

6 Global Cell Therapy Market, by Type

  • 6.1 Overview
  • 6.2 Autologous
  • 6.3 Allogeneic

7 Global Cell Therapy Market, by Product

  • 7.1 Overview
  • 7.2 Consumables (Vessel/Media/Serum/Reagent)
  • 7.3 Equipment
  • 7.4 Software & Other Services

8 Global Cell Therapy Market, by Technique

  • 8.1 Overview
  • 8.2 Stem Cell Therapy
  • 8.3 Cell Vaccine
  • 8.4 Adoptive Cell Transfer (ACT)
  • 8.5 Fibroblast Cell Therapy
  • 8.6 Chondrocyte Cell Therapy

9 Global Cell Therapy market, by Technology

  • 9.1 Overview
  • 9.2 Viral Vector Technology
  • 9.3 Cell Immortalization Technology
  • 9.4 Genome Editing Technology

10 Global Cell Therapy Market, by Cell Source

  • 10.1 Overview
  • 10.2 Bone Marrow
  • 10.3 Adipose Tissue
  • 10.4 Umbilical Cord Blood Derived Cells

11 Global Cell Therapy Market, by Application

  • 11.1 Overview
  • 11.2 Oncology
  • 11.3 Cardiovascular Disease (CVD)
  • 11.4 Orthopedic
  • 11.5 Wound Healing

12 Global Cell Therapy Market, by End User

  • 12.1 Overview
  • 12.2 Hospital & Clinics
  • 12.3 Regenerative Medicine Centers
  • 12.4 Research Institutes

13 Global Cell Therapy Market, by Region

  • 13.1 Overview
  • 13.2 Americas
    • 13.2.1 North America
    • 13.2.2 South America
  • 13.3 Europe
  • 13.4 Asia-Pacific
  • 13.5 Middle East & Africa

14 Competitive Landscape

  • 14.1 Introduction

15 Company Profiles

  • 15.1 Mesoblast Ltd
    • 15.1.1 Company Overview
    • 15.1.2 Financial Overview
    • 15.1.3 Products/Services Offered
    • 15.1.4 Key Developments
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Strategies
  • 15.2 Vericel Corporation
    • 15.2.1 Company Overview
    • 15.2.2 Financial Overview
    • 15.2.3 Products/Services Offered
    • 15.2.4 Key Developments
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Strategies
  • 15.3 Osiris Therapeutics, Inc.
    • 15.3.1 Company Overview
    • 15.3.2 Financial Overview
    • 15.3.3 Products/Services Offered
    • 15.3.4 Key Developments
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Strategies
  • 15.4 JCR Pharmaceuticals Co., Ltd
    • 15.4.1 Company Overview
    • 15.4.2 Financial Overview
    • 15.4.3 Products/Services Offered
    • 15.4.4 Key Developments
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Strategies
  • 15.5 NuVasive, Inc.
    • 15.5.1 Company Overview
    • 15.5.2 Financial Overview
    • 15.5.3 Products/Services Offered
    • 15.5.4 Key Developments
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Strategies
  • 15.6 Pharmicell Co., Ltd
    • 15.6.1 Company Overview
    • 15.6.2 Financial Overview
    • 15.6.3 Products/Services Offered
    • 15.6.4 Key Developments
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Strategies
  • 15.7 RTI Surgical Holdings, Inc.
    • 15.7.1 Company Overview
    • 15.7.2 Financial Overview
    • 15.7.3 Products/Services Offered
    • 15.7.4 Key Developments
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Strategies
  • 15.8 AlloSource
    • 15.8.1 Company Overview
    • 15.8.2 Financial Overview
    • 15.8.3 Products/Services Offered
    • 15.8.4 Key Developments
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Strategies
  • 15.9 Holostem Terapie Avanzate S.r.l.
    • 15.9.1 Company Overview
    • 15.9.2 Financial Overview
    • 15.9.3 Products/Services Offered
    • 15.9.4 Key Developments
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Strategies
  • 15.1 Medipost Co., Ltd
    • 15.10.1 Company Overview
    • 15.10.2 Financial Overview
    • 15.10.3 Products/Services Offered
    • 15.10.4 Key Developments
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Strategies

16 Appendix

  • 16.1 References
  • 16.2 Related Reports

List of Tables

  • TABLE 1 PRIMARY INTERVIEWS
  • TABLE 2 CELL THERAPY CLINICAL TRIALS IN 2018, BY PHASE
  • TABLE 3 CELL THERAPY CLINICAL TRIALS, BY TYPE (2018)
  • TABLE 4 GLOBAL CELL THERAPY MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL CELL THERAPY MARKET, FOR AUTOLOGOUS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL CELL THERAPY MARKET, FOR ALLOGENEIC, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL CELL THERAPY MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL CELL THERAPY MARKET, FOR CONSUMABLES (VESSEL/MEDIA/SERUM/REAGENT), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL CELL THERAPY MARKET, FOR EQUIPMENT, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL CELL THERAPY MARKET, FOR SOFTWARE & OTHER SERVICES, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL CELL THERAPY MARKET, BY TECHNIQUE, 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL CELL THERAPY MARKET, FOR STEM CELL THERAPY, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL CELL THERAPY MARKET, FOR CELL VACCINE, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL CELL THERAPY MARKET, FOR ADOPTIVE CELL TRANSFER (ACT), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL CELL THERAPY MARKET, FOR FIBROBLAST CELL THERAPY, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 16 GLOBAL CELL THERAPY MARKET, FOR CHONDROCYTE CELL THERAPY, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 17 GLOBAL CELL THERAPY MARKET, BY TECHNOLOGY, 2015-2023 (USD MILLION)
  • TABLE 18 GLOBAL CELL THERAPY MARKET, FOR VIRAL VECTOR TECHNOLOGY, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 19 GLOBAL CELL THERAPY MARKET, FOR CELL IMMORTALIZATION TECHNOLOGY, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 20 GLOBAL CELL THERAPY MARKET, FOR GENOME EDITING TECHNOLOGY, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 21 GLOBAL CELL THERAPY MARKET, BY CELL SOURCE, 2015-2023 (USD MILLION)
  • TABLE 22 GLOBAL CELL THERAPY MARKET, FOR BONE MARROW, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 23 GLOBAL CELL THERAPY MARKET, FOR ADIPOSE TISSUE, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 24 GLOBAL CELL THERAPY MARKET, FOR UMBILICAL CORD BLOOD DERIVED CELLS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 25 GLOBAL CELL THERAPY MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 26 GLOBAL CELL THERAPY MARKET, FOR ONCOLOGY, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 27 GLOBAL CELL THERAPY MARKET, FOR CARDIOVASCULAR DISEASE (CVD), BY REGION, 2015-2023 (USD MILLION)
  • TABLE 28 GLOBAL CELL THERAPY MARKET, FOR ORTHOPEDIC, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 29 GLOBAL CELL THERAPY MARKET, FOR WOUND HEALING, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 30 GLOBAL CELL THERAPY MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 31 GLOBAL CELL THERAPY MARKET, FOR HOSPITAL & CLINICS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 32 GLOBAL CELL THERAPY MARKET, FOR REGENERATIVE MEDICINE CENTERS, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 33 GLOBAL CELL THERAPY MARKET, FOR RESEARCH INSTITUTES, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 34 GLOBAL CELL THERAPY MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 35 AMERICAS: CELL THERAPY MARKET, BY REGION, 2015-2023 (USD MILLION)
  • TABLE 36 AMERICAS: CELL THERAPY MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 37 AMERICAS: CELL THERAPY MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 38 AMERICAS: CELL THERAPY MARKET, BY TECHNIQUE, 2015-2023 (USD MILLION)
  • TABLE 39 AMERICAS: CELL THERAPY MARKET, FOR STEM CELL THERAPY, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 40 AMERICAS: CELL THERAPY MARKET, FOR CELL VACCINE, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 41 AMERICAS: CELL THERAPY MARKET, FOR ADOPTIVE CELL TRANSFER (ACT), BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 42 AMERICAS: CELL THERAPY MARKET, BY TECHNOLOGY, 2015-2023 (USD MILLION)
  • TABLE 43 AMERICAS: CELL THERAPY MARKET, BY CELL SOURCE, 2015-2023 (USD MILLION)
  • TABLE 44 AMERICAS: CELL THERAPY MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 45 AMERICAS: CELL THERAPY MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 46 NORTH AMERICA: CELL THERAPY MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 47 NORTH AMERICA: CELL THERAPY MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 48 NORTH AMERICA: CELL THERAPY MARKET, BY TECHNIQUE, 2015-2023 (USD MILLION)
  • TABLE 49 NORTH AMERICA: CELL THERAPY MARKET, FOR STEM CELL THERAPY, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 50 NORTH AMERICA: CELL THERAPY MARKET, FOR CELL VACCINE, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 51 NORTH AMERICA: CELL THERAPY MARKET, FOR ADOPTIVE CELL TRANSFER (ACT), BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 52 NORTH AMERICA: CELL THERAPY MARKET, BY TECHNOLOGY, 2015-2023 (USD MILLION)
  • TABLE 53 NORTH AMERICA: CELL THERAPY MARKET, BY CELL SOURCE, 2015-2023 (USD MILLION)
  • TABLE 54 NORTH AMERICA: CELL THERAPY MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 55 NORTH AMERICA: CELL THERAPY MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 56 SOUTH AMERICA: CELL THERAPY MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 57 SOUTH AMERICA: CELL THERAPY MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 58 SOUTH AMERICA: CELL THERAPY MARKET, BY TECHNIQUE, 2015-2023 (USD MILLION)
  • TABLE 59 SOUTH AMERICA: CELL THERAPY MARKET, FOR STEM CELL THERAPY, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 60 SOUTH AMERICA: CELL THERAPY MARKET, FOR CELL VACCINE, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 61 SOUTH AMERICA: CELL THERAPY MARKET, FOR ADOPTIVE CELL TRANSFER (ACT), BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 62 SOUTH AMERICA: CELL THERAPY MARKET, BY TECHNOLOGY, 2015-2023 (USD MILLION)
  • TABLE 63 SOUTH AMERICA: CELL THERAPY MARKET, BY CELL SOURCE, 2015-2023 (USD MILLION)
  • TABLE 64 SOUTH AMERICA: CELL THERAPY MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 65 SOUTH AMERICA: CELL THERAPY MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 66 EUROPE: CELL THERAPY MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 67 EUROPE: CELL THERAPY MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 68 EUROPE: CELL THERAPY MARKET, BY TECHNIQUE, 2015-2023 (USD MILLION)
  • TABLE 69 EUROPE: CELL THERAPY MARKET, FOR STEM CELL THERAPY, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 70 EUROPE: CELL THERAPY MARKET, FOR CELL VACCINE, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 71 EUROPE: CELL THERAPY MARKET, FOR ADOPTIVE CELL TRANSFER (ACT), BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 72 EUROPE: CELL THERAPY MARKET, BY TECHNOLOGY, 2015-2023 (USD MILLION)
  • TABLE 73 EUROPE: CELL THERAPY MARKET, BY CELL SOURCE, 2015-2023 (USD MILLION)
  • TABLE 74 EUROPE: CELL THERAPY MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 75 EUROPE: CELL THERAPY MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 76 ASIA-PACIFIC: CELL THERAPY MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 77 ASIA-PACIFIC: CELL THERAPY MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 78 ASIA-PACIFIC: CELL THERAPY MARKET, BY TECHNIQUE, 2015-2023 (USD MILLION)
  • TABLE 79 ASIA-PACIFIC: CELL THERAPY MARKET, FOR STEM CELL THERAPY, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 80 ASIA-PACIFIC: CELL THERAPY MARKET, FOR CELL VACCINE, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 81 ASIA-PACIFIC: CELL THERAPY MARKET, FOR ADOPTIVE CELL TRANSFER (ACT), BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 82 ASIA-PACIFIC: CELL THERAPY MARKET, BY TECHNOLOGY, 2015-2023 (USD MILLION)
  • TABLE 83 ASIA-PACIFIC: CELL THERAPY MARKET, BY CELL SOURCE, 2015-2023 (USD MILLION)
  • TABLE 84 ASIA-PACIFIC: CELL THERAPY MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 85 ASIA-PACIFIC: CELL THERAPY MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 86 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, BY PRODUCT, 2015-2023 (USD MILLION)
  • TABLE 88 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, BY TECHNIQUE, 2015-2023 (USD MILLION)
  • TABLE 89 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, FOR STEM CELL THERAPY, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 90 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, FOR CELL VACCINE, BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 91 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, FOR ADOPTIVE CELL TRANSFER (ACT), BY TYPE, 2015-2023 (USD MILLION)
  • TABLE 92 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, BY TECHNOLOGY, 2015-2023 (USD MILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, BY CELL SOURCE, 2015-2023 (USD MILLION)
  • TABLE 94 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, BY APPLICATION, 2015-2023 (USD MILLION)
  • TABLE 95 MIDDLE EAST & AFRICA: CELL THERAPY MARKET, BY END USER, 2015-2023 (USD MILLION)
  • TABLE 96 TOP MANUFACTURERS IN THE GLOBAL CELL THERAPY MARKET

List of Figures

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 GLOBAL CELL THERAPY MARKET: MARKET STRUCTURE
  • FIGURE 3 RESEARCH PROCESS
  • FIGURE 4 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 5 GLOBAL CELL THERAPY MARKET SHARE, BY TYPE, 2017 (%)
  • FIGURE 6 GLOBAL CELL THERAPY MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
  • FIGURE 7 GLOBAL CELL THERAPY MARKET SHARE, BY PRODUCT, 2017 (%)
  • FIGURE 8 GLOBAL CELL THERAPY MARKET, BY PRODUCT, 2017 & 2023 (USD MILLION)
  • FIGURE 9 GLOBAL CELL THERAPY MARKET SHARE, BY TECHNIQUE, 2017 (%)
  • FIGURE 10 GLOBAL CELL THERAPY MARKET, BY TECHNIQUE, 2017 & 2023 (USD MILLION)
  • FIGURE 11 GLOBAL CELL THERAPY MARKET SHARE, BY TECHNOLOGY, 2017 (%)
  • FIGURE 12 GLOBAL CELL THERAPY MARKET, BY TECHNOLOGY, 2017 & 2023 (USD MILLION)
  • FIGURE 13 GLOBAL CELL THERAPY MARKET SHARE, BY CELL SOURCE, 2017 (%)
  • FIGURE 14 GLOBAL CELL THERAPY MARKET, BY CELL SOURCE, 2017 & 2023 (USD MILLION)
  • FIGURE 15 GLOBAL CELL THERAPY MARKET SHARE, BY APPLICATION, 2017 (%)
  • FIGURE 16 GLOBAL CELL THERAPY MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
  • FIGURE 17 GLOBAL CELL THERAPY MARKET SHARE, BY END USER, 2017 (%)
  • FIGURE 18 GLOBAL CELL THERAPY MARKET, BY END USER, 2017 & 2023 (USD MILLION)
  • FIGURE 19 GLOBAL CELL THERAPY MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 20 GLOBAL CELL THERAPY MARKET, BY REGION, 2017 & 2023 (USD MILLION)
  • FIGURE 21 AMERICAS: CELL THERAPY MARKET SHARE, BY REGION, 2017 (%)
Back to Top